Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 24.67% vs 5.28% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1,206.90% vs -115.10% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 27.89% vs 15.02% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -5.00% vs 1.69% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Shanxi C&Y Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 24.67% vs 5.28% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 14.83% vs 0.63% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 1,206.90% vs -115.10% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 77.35% vs 0.00% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is 27.89% vs 15.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 24.93% vs 15.38% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -5.00% vs 1.69% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 35.71% vs 61.54% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






